Physician

Shahid Shekhani, MD

According to 2025 Medicare claims, Shahid Shekhani, MD (NPI: 1649278870) practices medical oncology in the Janesville-Beloit, WI market, with the plurality of this provider's patient population coming from Rock, WI. This provider's primary affiliated billing organization is MERCY HEALTH SYSTEM CORPORATION (NPI: 1598718603; TIN: 390816848) and primary practice location at 53548-2940. Shekhani is affiliated with the Mercy Health Corporation (ACO ID: A2097) and Ascension Care Management Health Partners Wisconsin, LLC (ACO ID: A5329), participating under the MSSP model.

Shekhani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 678 traditional Medicare patients, billed 6,889 HCPCS/CPT codes, and received $273,315 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,676 prescription claims across 347 beneficiaries totaling $1,058,876 in drug costs, led by Tasigna (Nilotinib Hcl). 2021 DME data shows 25 claims. Open Payments data shows 3 records totaling $145. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $113,762 to $273,315. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,259,328 and ending at $1,058,876. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $18,752 to $1,296.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	388	5,173	$113,762
2016	484	3,693	$136,096
2017	565	3,862	$92,845
2018	432	2,454	$102,469
2019	550	4,112	$117,135
2020	598	3,874	$185,961
2021	592	4,616	$207,884
2022	601	8,043	$193,196
2023	641	4,389	$206,915
2024	678	6,889	$273,315

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	225	1,864	$1,259,328
2016	243	1,958	$1,541,173
2017	262	1,396	$1,522,321
2018	244	1,396	$1,723,386
2019	276	1,504	$1,384,817
2020	316	2,111	$2,143,680
2021	328	2,163	$1,676,028
2022	340	2,072	$1,752,629
2023	355	2,045	$1,633,274
2024	347	1,676	$1,058,876

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	33	288	$27,265
2016	42	359	$24,293
2017	N/R	43	$607
2018	N/R	31	$318
2019	N/R	35	$1,504
2020	N/R	41	$714
2021	N/R	25	$490
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	121	579	$108
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	65	65	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	570	1,555	$69
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	63	285	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	384	613	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tasigna	Nilotinib Hcl	13	364	$181,325
Venclexta	Venetoclax	12	276	$89,126
Abiraterone Acetate	Abiraterone Acetate	37	1,110	$82,380
Eliquis	Apixaban	81	4,350	$80,011
Xarelto	Rivaroxaban	16	1,020	$18,300

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$145	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Shahid Shekhani, MD?

Tedicare shows public-source Medicare data for Shahid Shekhani, MD (NPI 1649278870), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shahid Shekhani, MD have ACO affiliation data?

Shahid Shekhani, MD is shown with ACO affiliation data for Mercy Health Corporation (MSSP, ACO ID A2097) and Ascension Care Management Health Partners Wisconsin, LLC (MSSP, ACO ID A5329).

What billing organization is linked to Shahid Shekhani, MD?

Shahid Shekhani, MD is linked to MERCY HEALTH SYSTEM CORPORATION (billing NPI 1598718603) in the available physician profile data.

Does Shahid Shekhani, MD have Open Payments data?

Shahid Shekhani, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.